000 | 01825 a2200517 4500 | ||
---|---|---|---|
005 | 20250515102746.0 | ||
264 | 0 | _c20080515 | |
008 | 200805s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0707645 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhittle, B J R | |
245 | 0 | 0 |
_aAttenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMar 2008 |
||
300 |
_a983-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzothiazoles _xadministration & dosage |
650 | 0 | 4 |
_aColitis _xchemically induced |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aEpoxide Hydrolases _xantagonists & inhibitors |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPeroxidase _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTrinitrobenzenesulfonic Acid |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xdrug effects |
700 | 1 | _aVarga, C | |
700 | 1 | _aBerko, A | |
700 | 1 | _aHorvath, K | |
700 | 1 | _aPosa, A | |
700 | 1 | _aRiley, J P | |
700 | 1 | _aLundeen, K A | |
700 | 1 | _aFourie, A M | |
700 | 1 | _aDunford, P J | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 153 _gno. 5 _gp. 983-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0707645 _zAvailable from publisher's website |
999 |
_c17668560 _d17668560 |